down arrow

Telesis Bio, Inc.

  • Market Cap: N/A
  • Industry: Miscellaneous
  • ISIN: US1920031010
USD
0.02
0 (4.76%)

Dec 05

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

0.020.02

52 Week

0.001.55
Valuation
Technical
Day's Volume

CASH

100

Shareholding (Sep 2024)

FII

0.16%

Held by 4 FIIs

DII

66.79%

Held by 2 DIIs

Promoter

30.85%

How big is Telesis Bio, Inc.?

22-Jun-2025

As of Jun 18, Telesis Bio, Inc. has a market capitalization of 0.09 million, with net sales of 13.54 million and a net profit of -44.07 million over the latest four quarters. Shareholder's funds are 29.54 million, and total assets are 70.41 million as of Dec 23.

As of Jun 18, Telesis Bio, Inc. has a market capitalization of 0.09 million, categorizing it as a Micro Cap company.<BR><BR>As of Jun 18, the sum of Net Sales for the latest four quarters is 13.54 million, while the sum of Net Profit for the same period is -44.07 million.<BR><BR>As of Dec 23, the reporting period shows Shareholder's Funds at 29.54 million and Total Assets at 70.41 million.

Read More

Should I buy, sell or hold Telesis Bio, Inc.?

22-Jun-2025

Is Telesis Bio, Inc. technically bullish or bearish?

20-Sep-2025

As of July 21, 2025, Telesis Bio, Inc. shows a mildly bearish trend overall, with bearish daily moving averages and KST, despite mildly bullish weekly and monthly MACD indicators, and has significantly underperformed the S&P 500 with a year-to-date return of -99.75%.

As of 21 July 2025, the technical trend for Telesis Bio, Inc. has changed from bearish to mildly bearish. The weekly MACD indicates a mildly bullish stance, while the monthly MACD also shows mildly bullish. However, the daily moving averages are bearish, and the KST is bearish on both weekly and monthly time frames. The Dow Theory indicates a bearish trend on the monthly level, with no trend on the weekly. <BR><BR>In terms of performance, Telesis Bio has significantly underperformed compared to the S&P 500, with a year-to-date return of -99.75% versus the S&P 500's 12.22%. Overall, the current technical stance is mildly bearish, driven primarily by the bearish moving averages and KST, despite the mildly bullish MACD readings.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Miscellaneous

stock-summary
Market cap

USD 1 Million ()

stock-summary
P/E

0

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.88

stock-summary
Return on Equity

-796.13%

stock-summary
Price to Book

0.24

Revenue and Profits:
Net Sales:
2 Million
(Quarterly Results - Sep 2024)
Net Profit:
-6 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
83.33%
0%
83.33%
6 Months
-56.0%
0%
-56.0%
1 Year
-96.48%
0%
-96.48%
2 Years
-99.69%
0%
-99.69%
3 Years
-98.36%
0%
-98.36%
4 Years
-99.98%
0%
-99.98%
5 Years
0%
0%
0.0%

Telesis Bio, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News

Is Telesis Bio, Inc. technically bullish or bearish?

As of 21 July 2025, the technical trend for Telesis Bio, Inc. has changed from bearish to mildly bearish. The weekly MACD indicates a mildly bullish stance, while the monthly MACD also shows mildly bullish. However, the daily moving averages are bearish, and the KST is bearish on both weekly and monthly time frames. The Dow Theory indicates a bearish trend on the monthly level, with no trend on the weekly. In terms of performance, Telesis Bio has significantly underperformed compared to the S&P 500, with a year-to-date return of -99.75% versus the S&P 500's 12.22%. Overall, the current technical stance is mildly bearish, driven primarily by the bearish moving averages and KST, despite the mildly bullish MACD readings....

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
67.38%
EBIT Growth (5y)
-283.58%
EBIT to Interest (avg)
-24.00
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.88
Sales to Capital Employed (avg)
0.60
Tax Ratio
0.02%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
40.26%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
Industry P/E
Price to Book Value
0.02
EV to EBIT
-0.12
EV to EBITDA
-0.13
EV to Capital Employed
0.48
EV to Sales
0.26
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-414.01%
ROE (Latest)
-796.13%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
Bullish
No Signal
Bollinger Bands
Sideways
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
No Trend
Bearish
OBV
No Trend
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Sep 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Strategic Entities

Domestic Funds

Held in 4 Schemes (2.2%)

Foreign Institutions

Held by 4 Foreign Institutions (0.16%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'24 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Sep 2024 is -71.43% vs -16.42% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Sep 2024 is 41.51% vs 13.82% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1.60",
          "val2": "5.60",
          "chgp": "-71.43%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-4.40",
          "val2": "-9.30",
          "chgp": "52.69%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.20",
          "val2": "0.70",
          "chgp": "-71.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.80",
          "val2": "-0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-6.20",
          "val2": "-10.60",
          "chgp": "41.51%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-3,284.80%",
          "val2": "-1,819.00%",
          "chgp": "-146.58%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'23",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2023 is 0.36% vs 149.09% in Dec 2022",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2023 is 1.65% vs -24.36% in Dec 2022",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'23",
        "Dec'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "27.50",
          "val2": "27.40",
          "chgp": "0.36%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-31.00",
          "val2": "-43.60",
          "chgp": "28.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.10",
          "val2": "1.20",
          "chgp": "158.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-11.30",
          "val2": "-0.70",
          "chgp": "-1,514.29%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-47.70",
          "val2": "-48.50",
          "chgp": "1.65%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-1,277.80%",
          "val2": "-1,694.40%",
          "chgp": "41.66%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Sep'24 - YoYstock-summary
Sep'24
Sep'23
Change(%)
Net Sales
1.60
5.60
-71.43%
Operating Profit (PBDIT) excl Other Income
-4.40
-9.30
52.69%
Interest
0.20
0.70
-71.43%
Exceptional Items
-0.80
-0.00
Consolidate Net Profit
-6.20
-10.60
41.51%
Operating Profit Margin (Excl OI)
-3,284.80%
-1,819.00%
-146.58%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in quarter ended Sep 2024 is -71.43% vs -16.42% in Sep 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Sep 2024 is 41.51% vs 13.82% in Sep 2023

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'23stock-summary
Dec'23
Dec'22
Change(%)
Net Sales
27.50
27.40
0.36%
Operating Profit (PBDIT) excl Other Income
-31.00
-43.60
28.90%
Interest
3.10
1.20
158.33%
Exceptional Items
-11.30
-0.70
-1,514.29%
Consolidate Net Profit
-47.70
-48.50
1.65%
Operating Profit Margin (Excl OI)
-1,277.80%
-1,694.40%
41.66%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2023 is 0.36% vs 149.09% in Dec 2022

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2023 is 1.65% vs -24.36% in Dec 2022

All Annual Resultsstock-summary
stock-summaryCompany CV
About Telesis Bio, Inc. stock-summary
stock-summary
Telesis Bio, Inc.
Miscellaneous
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."